Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
2000 1
2002 12
2003 8
2004 18
2005 14
2006 14
2007 10
2008 14
2009 11
2010 12
2011 11
2012 25
2013 18
2014 17
2015 8
2016 15
2017 8
2018 8
2019 7
2020 7
2021 5
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Results by year

Filters applied: . Clear all
Page 1
Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer's Disease Drug Candidate.
Lindberg MF, Deau E, Miege F, Greverie M, Roche D, George N, George P, Merlet L, Gavard J, Brugman SJT, Aret E, Tinnemans P, de Gelder R, Sadownik J, Verhofstad E, Sleegers D, Santangelo S, Dairou J, Fernandez-Blanco Á, Dierssen M, Krämer A, Knapp S, Meijer L. Lindberg MF, et al. Among authors: meijer l. J Med Chem. 2023 Dec 14;66(23):15648-15670. doi: 10.1021/acs.jmedchem.3c01888. Epub 2023 Dec 5. J Med Chem. 2023. PMID: 38051674
Pharmacological inhibitors of cyclin-dependent kinases.
Knockaert M, Greengard P, Meijer L. Knockaert M, et al. Among authors: meijer l. Trends Pharmacol Sci. 2002 Sep;23(9):417-25. doi: 10.1016/s0165-6147(02)02071-0. Trends Pharmacol Sci. 2002. PMID: 12237154 Review.
Cyclin-dependent kinase inhibitors closer to market launch?
Galons H, Oumata N, Gloulou O, Meijer L. Galons H, et al. Among authors: meijer l. Expert Opin Ther Pat. 2013 Aug;23(8):945-63. doi: 10.1517/13543776.2013.789861. Epub 2013 Apr 22. Expert Opin Ther Pat. 2013. PMID: 23600454 Review.
[Cell cycle and molecular targets: CDK inhibition].
Carassou P, Meijer L, Le Moulec S, Aoun J, Bengrine-Lefèvre L. Carassou P, et al. Among authors: meijer l. Bull Cancer. 2012 Feb 1;99(2):163-71. doi: 10.1684/bdc.2011.1383. Bull Cancer. 2012. PMID: 21737380 Free article. Review. French.
Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome.
Lana-Elola E, Aoidi R, Llorian M, Gibbins D, Buechsenschuetz C, Bussi C, Flynn H, Gilmore T, Watson-Scales S, Haugsten Hansen M, Hayward D, Song OR, Brault V, Herault Y, Deau E, Meijer L, Snijders AP, Gutierrez MG, Fisher EMC, Tybulewicz VLJ. Lana-Elola E, et al. Among authors: meijer l. Sci Transl Med. 2024 Jan 24;16(731):eadd6883. doi: 10.1126/scitranslmed.add6883. Epub 2024 Jan 24. Sci Transl Med. 2024. PMID: 38266108 Free PMC article.
231 results